|
|
The IMP faculty represent numerous departments within the Emory University School of Medicine as well as the U.S. Centers for Disease Control. Click on a faculty member's name to get more information about them and their research.
|
|
|
· A
· B
· C
· D
· E
· F
· G
· H
· I
· J
· K
· L
· M
· N·
· O
· P
· Q
· R
· S
· T
· U
· V
· W
· X
· Y
· Z·
|
|
Rafi Ahmed, Ph.D.
Immunology and pathogenesis of chronic viral infections; immunological memory and vaccine development.
|
|
John Altman, Ph.D.
T-cell immune responses to HIV infection; vaccine development; development of T-cell memory.
|
 |
Rama R. Amara, Ph.D.
The goal of our laboratory is to develop novel therapeutic vaccines for HIV/AIDS, providing CD4 help for CD8 function.
|
|
Aftab Ansari, Ph.D.
My lab effort is focused on studies of the cellular and molecular mechanisms of
disease susceptibility and resistance in the SIV infected non-human primates.
|
|
Rustom Antia, Ph.D.
Modeling the dynamics of immune responses and infections.
|
|
David Archer, Ph.D.
Stem cell therapy for the treatment of inherited and acquired diseases.
|
|
Jeremy Boss, Ph.D.
Molecular immunology; regulation of major histocompatibility complex class II genes and tumor necrosis factor gene induction.
|
|
Richard Compans, Ph.D.
Cell biology of virus replication, focusing on the membrane glycoproteins of enveloped RNA viruses.
|
| |
Cynthia Derdeyn, Ph.D.
Regions of the HIV-1 envelope glycoproteins that modulate HIV-1 transmission and pathogenesis in sub-Saharan Africa.
|
|
Brian Evavold, Ph.D.
T-cell activation, antigen recognition; EAE autoimmunity model; role of SHP-1
phosphatase in T cell responses
|
|
Mary Galinski, Ph.D.
Discoveries of several P. vivax and P. falciparum merozoite vaccine candidates,
basic studies of simian malaria models, and investigations of the molecular
mechanisms that underpin antigen variation.
|
|
Andrew Gewirtz, Ph.D.
Elucidate the molecular mechanisms that regulate mucosal inflammation.
|
|
Linda Gooding, Ph.D.
Mechanisms of adenovirus persistence in human lymphoid tissues and oncogenic potential of adenoviruses in lymphocytes
|
 |
Jorg Goronzy, M.D., Ph.D.
Unique aspects of human immunology and its clinical application and we have considerable strength in the areas of human autoimmune disease and the aging of the immune system.
|
|
Arash Grakoui, Ph.D.
Our laboratory is committed to making significant contributions to the understanding of hepatitis C virus pathogenesis.
|
 |
Eric Hunter, Ph.D.
Elucidating the virus-cell interactions involved in the assembly and entry of retroviruses.
|
|
Joshy Jacob, Ph.D.
In situ analysis of B and T cell memory.
|
|
Jacqueline Katz, Ph.D.
Influenza virus immunity and pathogenesis.
|
 |
Gilbert Kersh, Ph.D.
Molecular mechanisms of thymocyte development; T cell responses to peptide/MHC complexes
|
|
Patrick Lammie, Ph.D.
T-cell responses to parasites, emphasis on filariasis and cryptosporidiosis.
|
|
Christian Larsen, M.D., Ph.D.
Understanding the fundamental mechanisms involved in T cell response to transplant tissues, and mechanisms involved in immunologic tolerance to self and transplanted tissues
|
 |
Aron Lukacher, M.D., Ph.D.
T-cell immunity against virus-induced tumors; pathogenesis of polyomavirus-associated kidney transplant rejection
|
|
Hinh Ly, Ph.D.
Major interests in our laboratory are to understand the roles of telomere-telomerase biology in human degenerative bone-marrow failure syndromes and to develop simple systems to study the replication of human hemorrhagic fever virus.
|
|
Janet M. McNicholl, M.D.
Molecular basis of T cell antigen recognition: applications to pathogenesis and vaccine research.
|
|
Jan Mead, Ph.D.
Immune mechanisms and chemotherapy of parasitic diseases, with emphasis on C. parvum, Microsporidia and T. vaginalis.
|
|
Robert Mittler, Ph.D.
The focus of our research program is the study of mouse and human T-cell costimulation pathways that are essential for productive T-cell responses
|
 |
Edward S. Mocarski, Jr., Ph.D.
My research focuses on the biology and pathogenesis of cytomegalovirus, an important opportunistic herpesvirus.
|
 |
Andrew Neish, M.D.
Current reseearch focuses on molecular events in prokaryotic-eukaryotic interactions.
|
|
Francis Novembre, Ph.D.
My laboratory is involved in researching the pathogenesis of human immunodeficiency virus (HIV)-infection utilizing the simian immunodeficiency virus (SIV)/macaque model system.
|
|
Roberto Pacifici, M.D.
Mechanism of action of estrogen in bone; estrogen regulation of T cell function and osteoclast differentiation.
|
|
Charles Parkos, M.D., Ph.D.
A major focus of the research in our laboratory is to better understand the
pathophysiology of musosal inflammation that is broadly applicable to many
inflammatory diseases.
|
|
Thomas Pearson, M.D., Ph.D.
Transplantation biology, focusing on T-cell costimulation and tolerance induction strategies.
|
|
Bali Pulendran, Ph.D.
Dendritic cells, toll receptors, innate immunity and adaptive immune responses.
|
|
Harriet Robinson, Ph.D.
The current research effort of the Robinson laboratory is focused on the development of an HIV/AIDS vaccine.
|
|
Paul Rota, Ph.D.
Molecular basis for virulence of viruses which cause human disease; strategies to control pathogens.
|
|
Periasamy Selvaraj, Ph.D.
The main interest of our laboratory is biochemical and functional characterization of cell surface receptors involved in immune cell recognition and adhesion.
|
|
William Shafer, Ph.D.
Genetics of antibiotic resistance; antimicrobial peptides; transcriptional regulation of gene expression; mechanisms of bacterial pathogenesis.
|
 |
Byeongwoon Song, Ph.D.
We are interested in HIV-1 replication and cellular restriction.
|
|
|
Paul Spearman, M.D.
The major focus of my laboratory is to understand the molecular and cellular basis for the assembly of HIV particles, and to develop particle-based HIV vaccines that can elicit effective neutralizing antibodies.
|
 |
Samuel Speck, Ph.D.
Pathogenesis of gamma-herpesviruses and development of lymphoma and other cancers.
|
|
David Steinhauer, Ph.D.
Functions of the influenza hemagglutinin in host cell entry; influenza assembly.
|
|
David S. Stephens, M.D.
Genetic basis and regulation of bacterial virulence components.
|
|
Edmund Waller, M.D., Ph.D.
Immune reconstitution after transplant. Allo-reactivity of memory vs naive
T-cells. Regulation of immune polarization of T-cells by dendritic cells.
|
 |
Cornelia Weyand, M.D., Ph.D.
Adaptive immune responses in autoimmune disease and immune-mediated tissue injury in inflammatory vasculopathies (giant cell vasculitis, acute coronoary syndromes, and rheumatoid vasculitis). |
|
Ifor Williams, M.D., Ph.D.
Chemokines and chemokine receptors in mucosal immune responses; lymphoid organogenesis in the small intestine
|
|
James C. Zimring, M.D., Ph.D.
My research focuses on identifying cellular and molecular mechanisms involved in establishing and maintaining immunological tolerance.
Return to Top of Page
|
